Statin therapy in the prevention and treatment of atrial fibrillation

Journal of Clinical Lipidology

Volumn 5, Issue 1, 2011, Pages 18-29

  Lee, Yi Lin ^a   Blaha, Michael J ^b   Jones, Steven R ^b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Ablation; Atrial fibrillation; Cardioversion; Congestive heart failure; Coronary artery disease; Paroxysmal; Perioperative; Statin

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLAVASTATIN; GELATINASE A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ABLATION THERAPY; ACUTE CORONARY SYNDROME; ARTICLE; CALCIUM TRANSPORT; CARDIOVERSION; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HEART SURGERY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 79151486289     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.11.002     Document Type: Review

References (81)

1. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
2. J. Heeringa, D.A. van der Kuip, and A. Hofman Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur Heart J 27 2006 949 953
3. L.L. Creswell, R.B. Schuessler, M. Rosenbloom, and J.L. Cox Hazards of postoperative atrial arrhythmias Ann Thorac Surg 56 1993 539 549
4. T.C. Andrews, S.C. Reimold, J.A. Berlin, and E.M. Antman Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized controlled trials Circulation 84 suppl 1991 I-236 I-244
5. Q. Caretta, C.A. Mercanti, and D. De Nardo Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting: multivariate analysis of preoperative, intraoperative and postoperative variables Eur Heart J 12 1991 1107 1111
6. M.F. Matangi, J.M. Neutze, K.J. Graham, D.G. Hill, A.R. Kerr, and B.G. Barratt-Boyes Arrhythmia prophylaxis after aorta-coronary bypass: the effect of mini-dose propranolol J Thorac Cardiovasc Surg 89 1985 439 443
7. S.A. Mills, G.V. Poole Jr., and R.H. Breyer Digoxin and propranolol in the prophylaxis of dysrhythmias after coronary artery bypass grafting Circulation 68 1983 II-222 II-225
8. S.R. Ommen, J.A. Odell, and M.S. Stanton Atrial arrhythmias after cardio-thoracic surgery N Engl J Med 336 1997 1429 1434
9. J.P. Mathew, M.L. Fontes, I.C. Tudor Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 2004 1720 1729
10. C.W. Hogue Jr., L.L. Creswell, D.D. Gutterman, L.A. Fleisher American College of Chest Physicians Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 2005 9
11. Y. Hirayama, H. Atarashi, and Y. Kobayashi Long-term effects of upstream therapy on paroxysmal atrial fibrillation in patients without overt heart diseases Int Heart J 50 2009 141 151
12. G. Ramani, M. Zahid, C.B. Good, A. Macioce, and A.F. Sonel Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome Am J Cardiol 1000 2007 404 405
13. B. Dahlöf, R. Devereux, and U. de Faire The Losartan Intervention for Endpoint reduction (LIFE) in hypertension study Am J Hypertens 10 1997 705 713
14. A. Ducharme, K. Swedberg, M.A. Pfeffer CHARM Investigators Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program Am Heart J 152 2006 86 92
15. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
16. H. Golzari, R.D. Cebul, and R.C. Bahler Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy Ann Intern Med 125 1996 311 323
17. G. Patti, M. Chello, and D. Candura Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study Circulation 114 2006 1455 1461
18. A. Tveit, M. Grundtvig, and T. Gundersen Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion Am J Cardiol 93 2004 780 782
19. A. Garcia-Fernandez, F. Marin, L. Mainar, V. Roldan, and J. Martinez Effect of statins on preventing recurrence of atrial fibrillation alter electrical cardioversion Am J Cardiol 98 2006 1299 1300
20. S. Lévy, A.J. Camm, S. Saksena Working Group on Arrhythmias, Working Group on Cardiac Pacing of the European Society of Cardiology, North American Society of Pacing and Electrophysiology International consensus on nomenclature and classification of atrial fibrillation Europace 5 2003 119 122
21. S. Cardin, D. Li, N. Thorin-Trescases, T.K. Leung, E. Thorin, and S. Nattel Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways Cardiovasc Res 60 2003 315 325
22. F. Ravelli Mechano-electric feedback and atrial fibrillation Prog Biophys Mol Biol 82 2003 137 149
23. J. Xu, G. Cui, and F. Esmailian Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation Circulation 109 2004 363 368
24. B.D. Hoit Matrix metalloproteinases and atrial structural remodeling J Am Coll Cardiol 42 2003 345 347
25. D. Li, S. Fareh, T.K. Leung, and S. Nattel Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort Circulation 100 1999 87 95
26. K. Kumagai, C. Khrestian, and A.L. Waldo Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance Circulation 95 1997 511 521
27. Bruins P, Velthuis H, Yazdanbakhsh A, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;1997:3542-3548.
28. M.K. Chung, D.O. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammation mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
29. J. Halonen, P. Halonen, and O. Järvinen Corticosteroids for the prevention of atrial fibrillation after cardiac surgery JAMA 297 2007 1562 1567
30. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
31. T.J. Wang, H. Parise, and D. Levy Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477
32. M.J. Mihm, F. Yu, and C.A. Carnes Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
33. C.A. Carnes, M.K. Chung, and T. Nakayama Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circ Res 89 2001 e32 e38
34. A. Shiroshita-Takeshita, G. Schram, J. Lavoie, and S. Nattel Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs Circulation 110 2004 2313 2319
35. D. Galaris, and P. Korantzopoulos On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate Free Radic Biol Med 22 1997 657 667
36. S. Bellosta, N. Ferri, F. Bernini, R. Paoletti, and A. Corsini Non-lipid-related effects of statins Ann Med 32 2000 164 176
37. J. Dernellis, and M. Panaretou Effect of C-reactive protein reduction on paroxysmal atrial fibrillation Am Heart J 150 2005 1064.e7 1064.e12
38. J. Dernellis, and M. Panaretou C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation Acta Cardiol 56 2001 375 380
39. F. Marín, D.A. Pascual, and V. Roldán Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting Am J Cardiol 97 2006 55 60
40. K.T. Weber Cardiac interstitium in health and disease: the fibrillar collagen network J Am Coll Cardiol 13 1989 1637 1652
41. D.N. Tziakas, G.K. Chalikias, and D.A. Stakos Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation Am J Cardiol 101 2008 199 202
42. Y. Young-Xu, S. Jabbour, and R. Goldberg Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease Am J Cardiol 92 2003 1379 1383
43. J. Godtfredsen Atrial fibrillation: course and prognosis: a follow-up study of 1212 cases H.E. Kulbertus, S.B. Olsson, M. Schlepper, Atrial Fibrillation 1982 AB Hassle Molndal, Sweden 34 45
44. N. Takahashi, A. Seki, K. Imataka, and J. Fujii Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients Jpn Heart J 22 1981 143 149
45. V. Fuster, L.E. Rydén, R.W. Asinger American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Circulation 104 2001 2118 2150
46. Y. Hirayama, H. Atarashi, and Y. Kobayashi Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation Circ J 69 2005 671 676
47. T. Kato, T. Yamashita, K. Sagara, H. Iinuma, and L.T. Fu Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study Circ J 68 2004 568 572
48. S.D. Corley, A.E. Epstein, J.P. DiMarco AFFIRM Investigators Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509-1513
49. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
50. C.N. Pellegrini, E. Vittinghoff, F. Lin, S.B. Hulley, and G.M. Marcus Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial Heart 95 2009 704 708
51. D.S. McLean, S. Ravid, M. Blazing, B. Gersh, A. Shui, and C.P. Cannon Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials Am Heart J 155 2008 298 302
52. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
53. T.J. Wang, M.G. Larson, and D. Levy Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
54. J.A.M. Foody, R. Shah, D. Galusha, F.A. Masoudi, E.P. Havranek, and H.M. Krumholz Statins and mortality among elderly patients hospitalized with heart failure Circulation 113 2006 1086 1092
55. F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigators N Engl J Med 335 1996 1001 1009
56. D. Mozaffarian, R. Nye, and W.C. Levy Statin therapy is associated with lower mortality among patients with severe heart failure Am J Cardiol 93 2004 1124 1129
57. A.S. Adabag, D.B. Nelson, and H.E. Bloomfield Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure Am Heart J 154 2007 1140 1145
58. I.R. Hanna, B. Heeke, and H. Bush Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction Heart Rhythm 3 2006 881 886
59. M.G. Dickinson, J.H. Ip, B. Olshansky SCD-HeFT Investigators Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT Heart Rhythm 3 2006 S49
60. C.-W. Siu, C.-P. Lau, and H.-F. Tse Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion Am J Cardiol 92 2003 1343 1345
61. J. Kjekshus, E. Apetrei, V. Barrios CORONA Group Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
62. F.A. Masoudi Statins for ischemic systolic heart failure N Engl J Med 357 2007 2301 2304
63. A.M. Gillis, M. Morck, and D.V. Exner Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation Eur Heart J 29 2008 1873 1880
64. J.S. Healey, W.D. Toff, and G.A. Lamas Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data Circulation 114 2006 11 17
65. J. Bunch, J.D. Day, B. Olshansky, K.Q. Stolen, and C.M. Mullin Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker for increased mortality Heart Rhythm 6 2009 2 8
66. M. Ozaydin, A. Dogan, E. Varol, S.M. Aslan, M. Ozturk, and A. Altinbas Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion Am J Cardiol 97 2006 1490 1493
67. G.H. Bardy, K.L. Lee, D.B. Mark Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure N Engl J Med 3 2005 225 237
68. The Antiarrhythmic versus Implantable Cardioverter Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable cardioverter defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
69. S.P. Bhavnani, C.I. Coleman, and C.M. White Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy Europace 10 2008 854 859
70. F. Naji, D. Suran, V. Kanic, D. Vokac, and M. Sabovic Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion Int Heart J 50 2009 153 160
71. B. Richter, M. Derntl, M. Marx, P. Lercher, and D. Gossinger Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation Am Heart J 153 2007 113 119
72. S.A. Mills, G.V. Poole Jr., and R.H. Breyer Digoxin and propranolol in the prophylaxis of dysrhythmias after coronary artery bypass grafting Circulation 68 1983 II-222 II-225
73. J.P. Mathew, R. Parks, and J.S. Savino Atrial fibrillation following coronary artery bypass surgery: predictors, outcomes, and resource utilization JAMA 276 1996 300 306
74. S.F. Aranki, D.P. Shaw, and D.H. Adams Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources Circulation 94 1996 390 397
75. G. Mariscalco, R. Lorusso, and C. Klersy Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery Ann Thorac Surg 84 2007 1158 1164
76. A. Kourliouros, A. De Souza, and N. Roberts Dose-related effect of statins on atrial fibrillation after cardiac surgery Ann Thorac Surg 85 2008 1515 1520
77. D. Amar, H. Zhang, P.M. Heerdt, B. Park, M. Fleisher, and H.T. Thaler Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein Chest 128 2005 3421 3427
78. A. Miceli, C. Fino, and B. Fiorani Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting Ann Thorac Surg 87 2009 1853 1858
79. K. Subramaniam, C.G. Koch, A. Bashour, M. O'Connor, M. Xu, and N. Starr Preoperative statin intake and morbid events after isolated coronary artery bypass grafting J Clin Anesth 20 2008 4 11
80. S. Virani, V. Nambi, and M. Razavi Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery Am Heart J 155 2008 541 546
81. S.S. Virani, V. Nambi, and V. Lee Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery? Am J Cardiol 102 2008 1235 1239